Glutamine addiction: an Achilles heel in esophageal cancers with dysregulation of CDK4/6
Understanding and overcoming resistance to cyclin-dependent kinase 4/6 (CDK4/6) inhibitors will be challenging. Recent work reveals that dysregulation of F-Box Protein 4 (FBXO4)-Cyclin D1 axis leads to mitochondrial dysfunction and drives glutamine-addiction in esophageal squamous cell carcinoma. Th...
Main Authors: | Shuo Qie, J. Alan Diehl |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-07-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2019.1610257 |
Similar Items
-
Targeting Glutamine Addiction in Gliomas
by: Marta Obara-Michlewska, et al.
Published: (2020-01-01) -
Exploiting the Achilles’ heel of cancer: disrupting glutamine metabolism for effective cancer treatment
by: Yuxin Fan, et al.
Published: (2024-03-01) -
Research Progress in Improving Efficacy of Radiotherapy by Targeting Glutamine Metabolism
by: QIAO Wanjia, et al.
Published: (2023-03-01) -
α-Ketoglutaramate—A key metabolite contributing to glutamine addiction in cancer cells
by: Arthur J. L. Cooper, et al.
Published: (2022-11-01) -
The Role of CDK Pathway Dysregulation and Its Therapeutic Potential in Soft Tissue Sarcoma
by: Johannes Tobias Thiel, et al.
Published: (2022-07-01)